EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome

Albane Badet iD, Clément Pruvot iD, Zoé Manssens, Wadih Abou-Chahla, Sébastien Buche

Pediatric Dermatology · 2025

DOI: 10.1111/pde.70082 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Albane Badet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Lille University Hospital, Lille, France. Hauptthemen laut MEDLINE: Chediak-Higashi Syndrome, Varicella Zoster Virus Infection, Herpesvirus 3, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chediak–Higashi syndrome ( CHS ) is a rare autosomal recessive primary immunodeficiency characterized by partial oculocutaneous albinism, neurologic involvement, and a predisposition to severe infections. Patients are particularly susceptible to developing hemophagocytic lymphohistiocytosis ( HLH ), which significantly worsens prognosis. We report the case of a 19‐year‐old male with CHS , under long‐term immunosuppressive therapy for chronic HLH , who developed chronic VZV infection. Despite treatment with valacyclovir, the lesions progressed, and virological investigations confirmed the diagnosis of acyclovir‐resistant varicella‐zoster virus ( VZV ). The clinical course was marked by the appearance of neurological symptoms and a fatal outcome. To our knowledge, this is the first reported fatal case of chronic VZV infection with systemic dissemination in a patient with CHS . This case highlights the risk of resistance associated with long‐term prophylaxis and the complexity of managing herpesvirus infections in immunocompromised patients receiving JAK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chediak-Higashi SyndromeVaricella Zoster Virus InfectionHerpesvirus 3, HumanHumansMaleYoung AdultFatal OutcomeAntiviral AgentsImmunocompromised Host

Stichwörter der Autor:innen

Chediak–Higashi syndromeJAK inhibitorsacyclovir resistancechronic VZV infectionherpesvirusesimmunodeficiencymacrophage activation syndrome

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Dermatology, Lille University Hospital, Lille, France.
  • University of Lille, Lille, France.
  • Pediatric Dermatology Department, Lille University Hospital, Lille, France.
  • Pathology Department, Lille University Hospital, Lille, France.
  • Pediatric Hematology and Oncology Department, Jeanne de Flandre Hospital, Lille University Hospital, Lille, France.

ORCID-Profile: Albane Badet, Clément Pruvot

Zitieren

APA

Badet, A., Pruvot, C., Manssens, Z., Abou-Chahla, W., & Buche, S. (2025). Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome. Pediatric Dermatology. https://doi.org/10.1111/pde.70082

Vancouver

Badet A, Pruvot C, Manssens Z, Abou-Chahla W, Buche S. Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome. Pediatric Dermatology. 2025. doi:10.1111/pde.70082

BibTeX
@article{Badet2025,
  author = {Badet, Albane and Pruvot, Clément and Manssens, Zoé and Abou-Chahla, Wadih and Buche, Sébastien},
  title = {Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.70082}
}
Kostenlos starten →